Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Sonoma Pharmaceuticals Inc. (SNOA)

5.07   0.02 (0.4%) 02-26 15:01
Open: 5.2999 Pre. Close: 5.05
High: 5.2999 Low: 5.06
Volume: 1,331 Market Cap: 9M
Sonoma Pharmaceuticals Inc is a speciality pharmaceutical company. It develops,identifies and commercialises therapies for dermatologic diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.308 - 5.337 5.337 - 5.365
Low: 4.983 - 5.021 5.021 - 5.056
Close: 5.015 - 5.07 5.07 - 5.12

Technical analysis

as of: 2020-02-26 4:32:30 PM
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 7.08     One year: 8.06
Support: Support1: 4.71    Support2: 3.92
Resistance: Resistance1: 6.06    Resistance2: 6.90
Pivot: 5.25
Moving Average: MA(5): 5.32     MA(20): 5.24
MA(100): 5.00     MA(250): 6.36
MACD: MACD(12,26): 0.09     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 35.25     %D(3): 51.38
RSI: RSI(14): 47.30
52-week: High: 10.35  Low: 3.33  Change(%): -39.4
Average Vol(K): 3-Month: 2538  10-Days: 1456

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
SNOA has closed above bottom band by 26.3%. Bollinger Bands are 44.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to SNOA's normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sonoma Pharmaceuticals : Prospectus filed pursuant to Rule 424(b)(3) | MarketScreener
Filed Pursuant to Rule 424 Registration No. 333-221477 PROSPECTUS SUPPLEMENT 448,949 shares of… | November 27, 2019

Sonoma Pharma readies equity offering; shares down 15% premarket
Sonoma Pharmaceuticals (SNOA) launches a public offering of common shares. Price, volume and terms have yet to be announced. Net proceeds will be used for

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 1.78
Shares Float (M) 1.31
% Held by Insiders 1.12
% Held by Institutions 8.03
Shares Short (K) 3
Shares Short P. Month (K)

Stock Financials

EPS -4.887
Book Value (p.s.) 7.790
PEG Ratio
Profit Margin -31.06
Operating Margin -36.74
Return on Assets (ttm) -29.1
Return on Equity (ttm) -57.1
Qtrly Rev. Growth 0.6
Gross Profit (p.s.) 4.989
Sales Per Share
EBITDA (p.s.) -3.792
Qtrly Earnings Growth
Operating Cash Flow (M) -5.27
Levered Free Cash Flow (M) -4.18

Stock Valuations

P/E -1.04
P/E Growth Ratio
P/BV 0.65
P/S 0.32
P/CF -1.71

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-06-19
Last Split Ratio 0.11
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.